Vivos Therapeutics Stock Price History
VVOS Stock | USD 3.38 0.18 5.62% |
If you're considering investing in Vivos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vivos Therapeutics stands at 3.38, as last reported on the 25th of November, with the highest price reaching 3.43 and the lowest price hitting 3.09 during the day. Vivos Therapeutics appears to be dangerous, given 3 months investment horizon. Vivos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0722, which indicates the firm had a 0.0722% return per unit of risk over the last 3 months. By inspecting Vivos Therapeutics' technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please review Vivos Therapeutics' Coefficient Of Variation of 1476.9, semi deviation of 5.53, and Risk Adjusted Performance of 0.061 to confirm if our risk estimates are consistent with your expectations.
At this time, Vivos Therapeutics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Common Stock Total Equity is likely to drop 1,566 in 2024. . At this time, Vivos Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.02 in 2024, whereas Price Earnings Ratio is likely to drop (1.17) in 2024. Vivos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vivos |
Sharpe Ratio = 0.0722
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | VVOS | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
8.31 actual daily | 73 73% of assets are less volatile |
Expected Return
0.6 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Vivos Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vivos Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.0187 | Enterprise Value Ebitda (0.21) | Price Sales 1.1036 | Shares Float 3.1 M | Wall Street Target Price 6.3 |
Vivos Therapeutics Stock Price History Chart
There are several ways to analyze Vivos Stock price data. The simplest method is using a basic Vivos candlestick price chart, which shows Vivos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 18, 2024 | 4.13 |
Lowest Price | October 9, 2024 | 2.29 |
Vivos Therapeutics November 25, 2024 Stock Price Synopsis
Various analyses of Vivos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vivos Stock. It can be used to describe the percentage change in the price of Vivos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vivos Stock.Vivos Therapeutics Accumulation Distribution | 27,013 | |
Vivos Therapeutics Price Rate Of Daily Change | 1.06 | |
Vivos Therapeutics Price Action Indicator | 0.21 | |
Vivos Therapeutics Price Daily Balance Of Power | 0.53 |
Vivos Therapeutics November 25, 2024 Stock Price Analysis
Vivos Stock Price History Data
The price series of Vivos Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 1.84 with a coefficient of variation of 10.54. The daily prices for the period are distributed with arithmetic mean of 2.79. The median price for the last 90 days is 2.71. The company experienced 1:25 stock split on 27th of October 2023.Open | High | Low | Close | Volume | ||
11/25/2024 | 3.25 | 3.43 | 3.09 | 3.38 | 272,517 | |
11/22/2024 | 3.01 | 3.27 | 3.00 | 3.20 | 272,693 | |
11/21/2024 | 2.89 | 2.99 | 2.80 | 2.95 | 106,393 | |
11/20/2024 | 2.88 | 2.97 | 2.77 | 2.89 | 69,545 | |
11/19/2024 | 2.63 | 2.86 | 2.51 | 2.83 | 116,623 | |
11/18/2024 | 2.82 | 2.94 | 2.70 | 2.71 | 156,379 | |
11/15/2024 | 3.15 | 3.15 | 2.76 | 2.84 | 224,351 | |
11/14/2024 | 3.12 | 3.23 | 2.95 | 3.12 | 212,297 | |
11/13/2024 | 3.25 | 3.25 | 2.99 | 3.12 | 189,544 | |
11/12/2024 | 3.25 | 3.25 | 3.12 | 3.21 | 147,918 | |
11/11/2024 | 3.17 | 3.48 | 3.07 | 3.21 | 487,580 | |
11/08/2024 | 2.87 | 3.25 | 2.82 | 3.09 | 299,559 | |
11/07/2024 | 2.74 | 2.89 | 2.68 | 2.84 | 150,841 | |
11/06/2024 | 2.68 | 2.77 | 2.67 | 2.71 | 72,035 | |
11/05/2024 | 2.71 | 2.71 | 2.65 | 2.65 | 30,772 | |
11/04/2024 | 2.70 | 2.75 | 2.61 | 2.69 | 54,297 | |
11/01/2024 | 2.54 | 2.72 | 2.54 | 2.68 | 87,254 | |
10/31/2024 | 2.73 | 2.73 | 2.52 | 2.52 | 107,933 | |
10/30/2024 | 2.90 | 2.90 | 2.70 | 2.70 | 139,337 | |
10/29/2024 | 2.93 | 2.93 | 2.77 | 2.90 | 76,700 | |
10/28/2024 | 2.71 | 2.99 | 2.62 | 2.90 | 399,109 | |
10/25/2024 | 2.70 | 2.76 | 2.65 | 2.65 | 79,005 | |
10/24/2024 | 2.66 | 2.69 | 2.56 | 2.67 | 86,716 | |
10/23/2024 | 2.66 | 2.66 | 2.56 | 2.64 | 67,580 | |
10/22/2024 | 2.68 | 2.71 | 2.52 | 2.63 | 77,238 | |
10/21/2024 | 2.67 | 2.95 | 2.61 | 2.70 | 330,674 | |
10/18/2024 | 2.45 | 2.74 | 2.40 | 2.67 | 187,561 | |
10/17/2024 | 2.50 | 2.53 | 2.40 | 2.44 | 81,072 | |
10/16/2024 | 2.50 | 2.55 | 2.42 | 2.53 | 73,975 | |
10/15/2024 | 2.44 | 2.54 | 2.38 | 2.47 | 69,194 | |
10/14/2024 | 2.51 | 2.59 | 2.43 | 2.46 | 105,788 | |
10/11/2024 | 2.30 | 2.53 | 2.30 | 2.53 | 84,808 | |
10/10/2024 | 2.27 | 2.43 | 2.23 | 2.31 | 151,964 | |
10/09/2024 | 2.39 | 2.40 | 2.27 | 2.29 | 146,225 | |
10/08/2024 | 2.41 | 2.52 | 2.37 | 2.41 | 248,428 | |
10/07/2024 | 2.51 | 2.58 | 2.39 | 2.42 | 90,364 | |
10/04/2024 | 2.59 | 2.61 | 2.50 | 2.51 | 77,516 | |
10/03/2024 | 2.37 | 2.52 | 2.31 | 2.50 | 134,839 | |
10/02/2024 | 2.49 | 2.50 | 2.39 | 2.43 | 224,833 | |
10/01/2024 | 2.60 | 2.62 | 2.43 | 2.52 | 198,435 | |
09/30/2024 | 2.67 | 2.80 | 2.60 | 2.61 | 155,913 | |
09/27/2024 | 3.06 | 3.09 | 2.64 | 2.70 | 981,184 | |
09/26/2024 | 3.24 | 3.29 | 3.02 | 3.06 | 234,735 | |
09/25/2024 | 3.02 | 3.35 | 3.02 | 3.24 | 424,124 | |
09/24/2024 | 2.91 | 3.15 | 2.90 | 3.04 | 307,436 | |
09/23/2024 | 3.04 | 3.18 | 2.93 | 2.93 | 394,925 | |
09/20/2024 | 3.18 | 3.32 | 2.78 | 3.08 | 878,433 | |
09/19/2024 | 3.26 | 3.29 | 2.93 | 3.22 | 3,619,824 | |
09/18/2024 | 3.42 | 5.95 | 3.02 | 4.13 | 73,742,536 | |
09/17/2024 | 3.00 | 3.15 | 2.72 | 2.80 | 168,206 | |
09/16/2024 | 3.10 | 3.10 | 2.86 | 2.95 | 16,900 | |
09/13/2024 | 2.88 | 2.95 | 2.77 | 2.95 | 16,267 | |
09/12/2024 | 3.00 | 3.00 | 2.80 | 2.86 | 30,369 | |
09/11/2024 | 2.97 | 3.15 | 2.94 | 3.04 | 51,704 | |
09/10/2024 | 2.97 | 3.27 | 2.88 | 3.02 | 111,566 | |
09/09/2024 | 2.79 | 2.99 | 2.65 | 2.96 | 63,100 | |
09/06/2024 | 2.70 | 2.70 | 2.50 | 2.62 | 30,195 | |
09/05/2024 | 2.63 | 2.72 | 2.57 | 2.64 | 13,700 | |
09/04/2024 | 2.69 | 2.75 | 2.51 | 2.58 | 33,955 | |
09/03/2024 | 2.62 | 2.80 | 2.59 | 2.61 | 34,600 | |
08/30/2024 | 2.83 | 2.86 | 2.70 | 2.71 | 15,199 |
About Vivos Therapeutics Stock history
Vivos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vivos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vivos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vivos Therapeutics stock prices may prove useful in developing a viable investing in Vivos Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.2 M | 899.6 K | |
Net Loss | -18.3 M | -19.2 M |
Vivos Therapeutics Stock Technical Analysis
Vivos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Vivos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vivos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vivos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vivos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.061 | |||
Jensen Alpha | 0.4681 | |||
Total Risk Alpha | (0.75) | |||
Sortino Ratio | 0.0655 | |||
Treynor Ratio | 0.8422 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.